Cost and Access in 2026 Price is the single biggest barrier for most patients
Heres the breakdown: Wegovy (pens): $199 per month for the first two months (applicable to 0.25 mg and 0.5 mg doses and valid only through June 30, 2026) $349 per month thereafter Wegovy pill: $149 per month for 1.5 mg dose $149 per month for 4 mg dose (through December 31, 2026) then $199 per month $299 per month for 9 mg and 25 mg doses These cash prices also come with membership costs ($39 for the first month, then $74 per month if you prepay for an annual plan or $149 per month if you stay on a monthly plan)
The clinical adoption of GLP-1 receptor agonists has outpaced manufacturing, leading to significant supply chain challenges that impact accessibility (Garvey, Diabetes, Obesity and Metabolism )
For example, one patient noticed that since they started their course of glutathione the ingrown hairs around the bikini line disappeared, others comment that theyve never felt so well, that their yearly hayfever didnt amount to anything, and that they feel their lung function has improved and they are using their inhalers less if they have asthma
Despite the associated risks, co- and multi-agonists herald the dawn of an era of more personalised metabolic medicine